(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page

U.S.-China Tariff Increase Updates

by Preyah | May 21, 2019 | Canadian Regulatory, Cosmetics, Medical Devices, Research/Science/Technology, U.S. Regulatory

The Office of the United States Trade Representative (USTR) formally published a notice in the Federal Register on May 10th of an increase in tariffs from 10% to 25% on all List 3 products being imported from China. The 10% Tariff remains in effect until June 1st for...

Can Sunscreen Absorption into the Bloodstream Pose Health Risks?

by Preyah | May 9, 2019 | Canadian Regulatory, Cosmetics, European Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory

A pilot study recently published in the medical journal, JAMA, found that it took just one day of sunscreen use for several active ingredients in sunscreen products to enter the blood stream at high levels. The sunscreen absorption study, which was conducted by a...

Effects of Sterigenics Plant Shutdown on Medical Device Licences (MDL) in Canada

by Preyah | May 1, 2019 | Canadian Regulatory, Medical Devices, Research/Science/Technology, U.S. Regulatory

Sterigenics, an international company who provides sterilization solutions for medical devices, pharmaceutical, commercial, and food industries, has shut down its plant in Willowbrook, Illinois. The recent shutdown, which took place in February 2019, was linked to the...

Recent Posts

  • A Summary of International Efforts in Minimizing the Spread of COVID-19
  • Health Canada Extension on Nitrosamine Risk Assessments
  • Updates to FDA Regulations for COVID-19 Essential Products
  • Health Canada’s Actions to Minimize the Spread of COVID-19
  • Less Testing for Imported Low-Risk OTC Drugs – Temporarily

Recent Comments

  • Neoma Wheeington on California Senate Passes Cosmetics Fragrance Disclosure Bill
  • Alpha Elio on How to Handle Complaints Made About Your Innovation
  • Mariam Jura on New Hair and Skin Models Indicate an Animal Friendly Future
  • Lyda Jagher on Can Health Features on Devices Detect Dementia Signs?
  • Brianbut on 49th Amendment to the International Fragrance Association Code of Practice

Archives

  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018

Categories

  • Canadian Regulatory
  • Cosmetics
  • European Regulatory
  • Events/Company Updates
  • Innovation
  • Innovation
  • Medical Devices
  • Natural Health Products
  • OTC Drugs
  • Our View
  • Research/Science/Technology
  • U.S. Regulatory
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2020 Focal Point Research Inc.
Privacy Policy | Terms of Use
Website Design and Development by PLAY

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

 


Jennifer Porter

Since joining the FPR team in 2011, Jennifer has become our VP/GM managing all staff and projects in the corporate portfolio. She is responsible for finance, accounting and all aspects of IT.

Jennifer obtained an MBA from University of Redlands, located in Southern California and a B.A. in Psychology from Hawaii Pacific University. When not supporting the needs for her clients, Jennifer enjoys golfing, live music, and traveling.